199 related articles for article (PubMed ID: 32497486)
1. Efficacy of co-immunization with the DNA and peptide vaccines containing SYCP1 and ACRBP epitopes in a murine triple-negative breast cancer model.
Safavi A; Kefayat A; Mahdevar E; Ghahremani F; Nezafat N; Modarressi MH
Hum Vaccin Immunother; 2021 Jan; 17(1):22-34. PubMed ID: 32497486
[TBL] [Abstract][Full Text] [Related]
2. Production, purification, and in vivo evaluation of a novel multiepitope peptide vaccine consisted of immunodominant epitopes of SYCP1 and ACRBP antigens as a prophylactic melanoma vaccine.
Safavi A; Kefayat A; Sotoodehnejadnematalahi F; Salehi M; Modarressi MH
Int Immunopharmacol; 2019 Nov; 76():105872. PubMed ID: 31499268
[TBL] [Abstract][Full Text] [Related]
3. Immunoprotective effect of an in silico designed multiepitope cancer vaccine with BORIS cancer-testis antigen target in a murine mammary carcinoma model.
Mahdevar E; Kefayat A; Safavi A; Behnia A; Hejazi SH; Javid A; Ghahremani F
Sci Rep; 2021 Nov; 11(1):23121. PubMed ID: 34848739
[TBL] [Abstract][Full Text] [Related]
4. Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c mice.
Han Y; Zhou A; Lu G; Zhao G; Wang L; Guo J; Song P; Zhou J; Zhou H; Cong H; He S
BMC Infect Dis; 2017 Jan; 17(1):59. PubMed ID: 28077075
[TBL] [Abstract][Full Text] [Related]
5. Immune responses against a new HIV-1 p24-gp41/pCAGGS-IL-12 DNA vaccine in Balb/c mice.
Roodbari F; Sabahi F; Sarbolouki MN; Barkhordari F; Adeli A; Jamedar A; Mahboudi F
Iran J Immunol; 2012 Jun; 9(2):86-97. PubMed ID: 22735796
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of two HIV-1 multiepitope polypeptides for stimulation of immune responses in BALB/c mice.
Kardani K; Hashemi A; Bolhassani A
Mol Immunol; 2020 Mar; 119():106-122. PubMed ID: 32007753
[TBL] [Abstract][Full Text] [Related]
7. Immune response of mice to a latency membrane protein 2 multiepitope antigen of Epstein-Barr virus applied as DNA vaccine and/or peptide vaccine.
Li W; Chen Q; Chen H; Rao P; Xue X; Chen S; Zhu S; Zhang L
Acta Virol; 2013; 57(1):51-8. PubMed ID: 23530824
[TBL] [Abstract][Full Text] [Related]
8. Immunogenic evaluation of FMD virus immuno-dominant epitopes coupled with IL-2/FcIgG in BALB/c mice.
Doosti M; Nassiri M; Nasiri K; Tahmoorespur M; Zibaee S
Microb Pathog; 2019 Jul; 132():30-37. PubMed ID: 31004723
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice.
Foroutan M; Ghaffarifar F; Sharifi Z; Dalimi A
Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101413. PubMed ID: 31954995
[TBL] [Abstract][Full Text] [Related]
10. Induction of Humoral and Cellular Immune Responses in Mice by Multiepitope Vaccines Composing of Both T and B Lymphocyte Epitopes of MAGE-A3 which are Recombined into HBcAg.
Chen Q; Li W; Wang P; Shao H; Ding Y; Wang W; Cen D; Cai Y; Xue X; Zhang L; Zhu G
Protein Pept Lett; 2017; 24(10):947-954. PubMed ID: 28641561
[TBL] [Abstract][Full Text] [Related]
11. The effect of co-administration of adjuvants with a nanoparticle-based genetic vaccine delivery system on the resulting immune responses.
Cui Z; Mumper RJ
Eur J Pharm Biopharm; 2003 Jan; 55(1):11-8. PubMed ID: 12551699
[TBL] [Abstract][Full Text] [Related]
12. Immunization using male germ cells and gametes as rich sources of cancer/testis antigens for inhibition of 4T1 breast tumors' growth and metastasis in BALB/c mice.
Safavi A; Kefayat A; Ghahremani F; Mahdevar E; Moshtaghian J
Int Immunopharmacol; 2019 Sep; 74():105719. PubMed ID: 31272065
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of Multi-Epitope DNA and Peptide Vaccine Candidates Based on Core, E2, NS3 and NS5B HCV Epitopes in BALB/c Mice.
Pishraft Sabet L; Taheri T; Memarnejadian A; Mokhtari Azad T; Asgari F; Rahimnia R; Alavian SM; Rafati S; Samimi Rad K
Hepat Mon; 2014 Oct; 14(10):e22215. PubMed ID: 25419219
[TBL] [Abstract][Full Text] [Related]
14. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
[TBL] [Abstract][Full Text] [Related]
15. The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.
Martín-Márquez BT; Satoh M; Hernández-Pando R; Martínez-García EA; Petri MH; Sandoval-García F; Pizano-Martinez O; García-Iglesias T; Corona-Meraz FI; Vázquez-Del Mercado M
PLoS One; 2021; 16(10):e0259114. PubMed ID: 34705865
[TBL] [Abstract][Full Text] [Related]
16. A Multiple Antigen Peptide Vaccine Containing CD4
Gu Y; Sun X; Huang J; Zhan B; Zhu X
J Immunol Res; 2020; 2020():2074803. PubMed ID: 32377530
[TBL] [Abstract][Full Text] [Related]
17. Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice.
Wagner S; Jasinska J; Breiteneder H; Kundi M; Pehamberger H; Scheiner O; Zielinski CC; Wiedermann U
Breast Cancer Res Treat; 2007 Nov; 106(1):29-38. PubMed ID: 17203384
[TBL] [Abstract][Full Text] [Related]
18. Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon.
Rodriguez F; Harkins S; Slifka MK; Whitton JL
J Virol; 2002 May; 76(9):4251-9. PubMed ID: 11932390
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of immunogenicity of a therapeutic cervical cancer DNA-based vaccine by co-application of sequence-optimized genetic adjuvants.
Ohlschläger P; Quetting M; Alvarez G; Dürst M; Gissmann L; Kaufmann AM
Int J Cancer; 2009 Jul; 125(1):189-98. PubMed ID: 19358269
[TBL] [Abstract][Full Text] [Related]
20. T- and B-cell epitopes in the secreted Mycobacterium bovis antigen MPB70 in mice.
Tollefsen S; Pollock JM; Lea T; Harboe M; Wiker HG
Scand J Immunol; 2003 Feb; 57(2):151-61. PubMed ID: 12588661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
